Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov;269(11):6152-6154.
doi: 10.1007/s00415-022-11222-8. Epub 2022 Jun 16.

Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report

Camilla M M Strano #  1   2 , Benedetta Sorrenti #  1   2 , Luca Bosco  1   2 , Yuri M Falzone  1 , Raffaella Fazio  1 , Massimo Filippi  3   4   5   6   7
Affiliations
Case Reports

Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report

Camilla M M Strano et al. J Neurol. 2022 Nov.
No abstract available

PubMed Disclaimer

References

    1. Gilhus NE (2016) Myasthenia gravis Longo DL, editor. N Engl J Med 375(26):2570–2581 - DOI
    1. Patriquin CJ, Kuo KHM (2019) Eculizumab and beyond: the past, present, and future of complement therapeutics. Transfus Med Rev 33(4):256–265 - DOI
    1. Cheng W, Sun T, Liu C, Zhou Z, Duan J, Zhao Y et al (2021) A systematic review of myasthenia gravis complicated with myocarditis. Brain Behav [Internet]. 11:8. https://doi.org/10.1002/brb3.2242 - DOI
    1. Frampton JE (2020) Eculizumab: a review in neuromyelitis optica spectrum disorder. Drugs 80(7):719–727 - DOI
    1. Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P et al (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355(12):1233–1243 - DOI

MeSH terms

Substances

LinkOut - more resources